Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Obesity (Silver Spring). 2020 Apr 9;28(5):860–869. doi: 10.1002/oby.22756

Table 2:

Comparison of Pre and End Intervention Measures

Mean (SD) TRE (n=11) P* value relative to pre - intervention Non-TRE (n=9) P* value relative to pre-intervention P value comparing pre-post change between TRE and non-TRE
Pre-Intervention End Intervention Pre-Intervention End Intervention
Weight
Weight 95.2 (22.6) 91.6 (21.5) <0.01 100.9 (28.1) 99.4 (28.1) 0.09 0.04
Body Composition
Lean Mass:Total (kg) 50.0 (9.8) 48.6 (9.9) <0.01 51.1 (8.7) 51.0 (7.8) 0.81 0.03
Lean Mass:Trunk (kg) 23.5 (4.6) 22.9 (4.7) 0.08 23.6 (4.3) 23.3 (3.6) 0.24 0.50
Lean Mass:Arms (kg) 5.6 (1.5) 5.4 (1.4) 0.07 5.8 (1.0) 5.7 (1.1) 0.38 0.36
Lean Mass:Legs (kg) 17.8 (3.6) 17.2 (3.7) <0.01 18.6 (3.9) 18.8 (3.6) 0.22 <0.01
Fat mass: Total (kg) 41.1 (16.8) 39.4 (16.4) <0.01 45.6 (20.7) 44.7 (20.8) 0.10 0.31
Fat mass: Visceral (kg) 1.7 (1.3) 1.4 (1.1) 0.04 1.1 (0.6) 1.1 (0.6) 0.63 0.04
%body fat 44.0 (9.5) 43.7 (9.6) 0.51 45 (8.5) 44.8 (9.4) 0.14 0.48
Eating Habits
Eating Window (hours) 15.2 (0.7) 9.9 (2.0) <0.01 15.5 (1.1) 15.1 (1.1) 0.24 <0.01
Eating Occasions (# occasions/day) 5.4 (1.6) 3.8 (0.8) <0.01 5.6 (2.0) 4.9 (1.6) 0.01 0.02
Blood Pressure
Systolic blood pressure (mmHg) 132 (13.0) 121 (16) 0.12 123 (13) 115 (12) 0.07 0.78
Diastolic blood pressure (mmHg) 85# (4) 79 (15) 0.22 79 (8) 72 (7) 0.02 0.77
Glycemic measures
Hemoglobin A1c (%) 5.4 (0.4) 5.4 (0.4) 0.74 5.6 (0.4) 5.6 (0.4) 0.59 0.57
HOMA-IR 2.5 (1.6) 2.4 (1.9) 0.75 2.3 (1.2) 2.2 (1.9) 0.90 0.95
Matsuda Index 4.4 (2.6) 5.2 (3.4) 0.12 5.2 (3.4) 5.9 (4.3) 0.30 0.70
Fasting glucose (mg/dl) 95 (10) 87 (9) <0.01 95 (13) 88 (3) 0.17 0.98
Fasting insulin (mU/L) 11 (6) 11 (7) 0.84 10 (5) 10 (8) 0.97 0.84
2 hour OGTT glucose value (mg/dL) 142# (45) 126 (21) 0.14 96 (24) 107 (26) 0.14 0.98
Physical activity
% time in Sedentary Activity 46.0 (5.5) 45.8 (3.7) 0.87 47.6 (5.6) 49.1 (4.6) 0.42 0.47
% time in Light Activity 41.1 (1.9) 42.0 (3.1) 0.37 39.4 (4.6) 38.9 (3.3) 0.75 0.42
% time in Moderate+Vigorous Activity 12.9 (4.5) 12.2 (3.5) 0.52 13.1 (3.5) 12.0 (4.1) 0.57 0.83
CGMS measures
Average glucose (mg/dL) 93 (10) 96 (9) 0.39 91 (13) 92 (9) 0.66 0.67
Coefficient of Variation (%) 17.7 (3.8) 16.3 (2.3) 0.32 27.0 (27.4) 17.0 (3.6) 0.33 0.40
Standard Deviation (mg/dL) 16.5 (3.5) 15.7 (3.2) 0.58 15.7 (4.0) 15.5 (2.9) 0.85 0.76
% time where blood sugars below target (<70 mg/dL) 6.4 (5.1) 3.0 (2.1) 0.07 7.7 (8.8) 8.3 (9.2) 0.76 0.14
% time where blood sugars within target (70–180 mg/dL) 92.9 (5.5) 97 (2.1) 0.03 92.0 (9.3) 92 (9.2) 0.86 0.09
% time where blood sugars above target (>180 mg/dL) 0.7 (1.4) 0 (0) 0.12 0.3 (1.0) 0 (0) 0.35
Lipid Measures
HDL (mg/dL) 50 (14) 51 (14) 0.97 60 (18) 67 (19) 0.57 0.66
Triglycerides (mg/dL) 144# (54) 106 (39) 0.02 87 (21) 87 (27) 0.90 0.62††
LDL (mg/dL) 95 (24) 104 (31) 0.55 105 (19) 106 (19) 0.68 0.84
*

p value is for significance of absolute change relative to pre-intervention

#

indicates significantly different between TRE and non-TRE groups pre-intervention p<0.05

After adjusting for pre-intervention 2 hour OGTT glucose value, unadjusted p value is 0.05

††

After adjusting for pre-intervention triglyceride value, unadjusted p value is 0.07